Urinary incontinence in Japanese women with chronic obstructive pulmonary disease: Review

Journal of Physical Therapy Science

Volumn 17, Issue 2, 2006, Pages 119-124

  Hirayama, Fumi ^a   Binns, Colin W ^a   Lee, Andy H ^a   Senjyu, Hideaki ^b  

^a CURTIN UNIVERSITY   (Australia)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Smoking; Urinary incontinence

Indexed keywords

EID: 33645019868     PISSN: 09155287     EISSN: 09155287     Source Type: Journal    
DOI: 10.1589/jpts.17.119     Document Type: Review

References (40)

1. Pauwels R: Global Initiative for Chronic Obstructive Lung Disease. http://www.goldcopd.dk/index_uk.htm. USA: National Heart, Lung, and Blood Institute, National Institutes of Health, USA, and Who, 2003.
2. American Thoracic Society and European Respiratory Society: Standards for the diagnosis and management of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J, 2004, 23: 932-946.
3. Burdon JGW, Edwards RL: The COPDX plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2003. MJA, 2003, 178: s1-s39.
4. Pauwels RA, Rabe K: Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet, 2004, 364: 613-620.
5. Department of Health and Human Services Center for Disease Control and Prevention: Facts about chronic obstructive pulmonary disease. http://www.cdc.gov/nceh/airpollution/copd/copdfag.pdf. Atlanta: Center for Disease Control and Prevention, 2003.
6. Mannino DM, Homa M, Akinbami LJ, et al.: Chronic obstructive pulmonary disease surveillance United States, 1971-2000. Morb Mortal Wkly Rep, 2002, 51: 1-16.
7. Teramoto S, Yamamoto H, Yamaguchi Y, et al.: Global burden of COPD in Japan and Asia. Lancet, 2003, 362: 1764-1765.
8. Fukuchi Y, Nishimura M, Ichinose M, et al.: COPD in Japan: the Nippon epidemiology study. Respirology, 2004, 9: 458-465.
9. Takemura K, Sasaki T, Miura N, et al.: The incidence of chronic obstructive pulmonary disease. Jpn Med J, 2003, 4140: 51-55 (in Japanese).
10. Ministry of Health Labour and Welfare: Tobacco or Health. http://www.health-net.or.jp/tobacco/product/pd090000.html. Tokyo: Ministry of Health Labour and Welfare, 2002 (in Japanese).
11. Ministry of Health Labour and Welfare: Survey for smoking and health issue in Japan. http://www1.mhlw.go.jp/houdou/1111/h1111-2_11.html. Tokyo: Ministry of Health Labour and Welfare, 2003 (in Japanese).
12. World Health Organization: Tobacco or Health: A Global Status Report Country Profiles by Region. http://www.cdc.gov/tobacco/who/japan.htm. Atlanta: WHO, 1998.
13. Chinese Academy of Preventive Medicine Department of Disease Control Ministry of Health P.R. China Chinese Association of Smoking or Health Office of Committee of the National Patriotic Health Campaign: Smoking and health in China 1996 National Prevalence Survey of Smoking Pattern. http://www.jhsph.edu/test/IGTC_old/research/survey.pdf. Beijing: Chinese Academy of Preventive Medicine Department of Disease Control Ministry of Health, P.R. China, 2002.
14. Jee SH, Samet JM, Ohrr H, et al.: Smoking and cancer risk in Korean men and women. Cancer Causes Control, 2004, 15: 341-348.
15. Morrow M, Barraclough S: Tobacco control and gender in south-east Asia. Part II: Singapore and Vetnam. Health Promotion Int, 2003, 18: 373-380.
16. US Census Bureau: Population Pyramid Summary for Japan. http://www.census.gov/cgi-bin/ipc/idbpyrs.pl?cty=JA&out= s&ymax=250. Washington DC: US Census Bureau, 2003.
17. Ministry of Health Labour and Welfare: Ministry of Health Labour and Welfare statistical database. http://wwwdbtk.mhlw.go.jp/toukei/index.html. Tokyo: Ministry of Health and Welfare, 2003 (in Japanese).
18. Fukuchi Y, Nishimura M, Masakazu I, et al.: Welcome to COPD-info.net. http://www.copd-info.net/what/dorekurai.html. Tokyo: MC & P Co., Ltd., 2002 (in Japanese).
19. Nishimura S, Zaher C: Cost impact of COPD in Japan: Opportunities and challenges? Respirology, 2004, 9: 466-473.
20. Eva UF, Gun W, Preben K: Prevalence of urinary and fecal incontinence and symptoms of genital prolapse in women. Acta Obstet Gynecol Scand, 2003, 82: 280-286.
21. Hald PT: Epidemiology and natural history of urinary incontinence (UI), Economics of incontinence. In: INCONTINENCE 2nd ed. United Kingdom: Plymbridge Distributors Ltd., 2002, pp 165-201, 966-983.
22. Hannestad YS, Rortveit G, Sandvik H, et al.: A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. J Clin Epidemiol, 2000, 53: 1150-1157.
23. Hampel C, Wienhold D, Benken N, et al.: Definition of overactive bladder and epidemiology of urinary incontinence. Urology, 1997, 50: 4-14.
24. White D, Stiller K, Roney F: The prevalence and severity of symptoms of incontinence in adult cystic fibrosis patients. Physiother Theory Pract, 2000, 16: 35-42.
25. Nixon GM, Glazner JA, Martin JM, et al.: Urinary incontinence in female adolescents with cystic fibrosis. Pediatrics, 2002, 110: e22.
26. Orr A, McVean RJ, Webb AK, et al.: Questionnaire survey of urinary incontinence in women with cystic fibrosis. BMJ, 2001, 322: 1521.
27. Maggi S, Minicuci N, Langlois J, et al.: Prevalence rate of urinary incontinence in community-dwelling elderly individuals: the Veneto study. J Gerontol A Biol Sci Med Sci, 2001, 56: M14-M18.
28. Brown JS, Seeley DG, Fong J, et al.: Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol, 1996, 87: 715-721.
29. Bortolotti A, Bernardini B, Colli E, et al.: Prevalence and risk factors for urinary incontinence in Italy. Eur Urol, 2000, 37: 30-35.
30. Cornacchia M, Zenorini A, Perobelli S, et al.: Prevalence of urinary incontinence in women with cystic fibrosis. BJU Int, 2001, 88: 44-48.
31. Diokno AC: Epidemiology and psychosocial aspects of incontinence. Urol Clin North Am, 1995, 22: 481-485.
32. Moran F, Bradley JM, Boyle L, et al.: Incontinence in adult females with cystic fibrosis: a Northern Ireland survey. Int J Clin Pract, 2003, 57: 182, 183.
33. Sherburn M, Chase J, Button B: The prevalence and severity of symptoms of incontinence in adult women with chronic lung disease. ICS, 2002: 245.
34. Rortveit G, Hannestad YS, Daltveit AK, et al.: Age- and type-dependent effects of parity on urinary incontinence: the Norwegian EPINCONT study. Obstet Gynecol, 2001, 98: 1004-1010.
35. Dolan LM, Casson K, Mcdonald P, et al.: Urinary incontinence in Northern Ireland: a prevalence study. BJU Int, 1999, 83: 760-766.
36. Chiarelli P, Brown W, McElduff P: Leaking urine: prevalence and associated factors in Australian women. Neurourol Urodyn, 1999, 18: 567-577.
37. Luna MT, Hirakawa T, Nakano H: Urinary incontinence in women seen in the obstetrics and gynecology clinic. Int Urogynecol J Pelvic Floor Dysfunct, 2000, 11: 277-281.
38. Hirai K, Ishiko O, Sumi T, et al.: Indifference and resignation of Japanese women toward urinary incontinence. Int J Gynaecol Obstet, 2001, 75: 89-91.
39. Lin HH, Torng PL, Sheu BC, et al.: Urodynamically age-specific prevalence of urinary incontinence in women with urinary symptoms. Neurourol Urodyn, 2003, 22: 29-32.
40. Wanger TH, Hu T-W: Economic costs of urinary incontinence in 1995. Urology, 1998, 51: 355-361.